Part 201. PART 201—LABELING
- SUBPART A [§ 201.1 - § 201.26] - Subpart A—General Labeling Provisions
- SUBPART B [§ 201.50 - § 201.58] - Subpart B—Labeling Requirements for Prescription Drugs and/or Insulin
- SUBPART C [§ 201.60 - § 201.80] -
- SUBPART D [§ 201.100 - § 201.129] - Subpart D—Exemptions From Adequate Directions for Use
- SUBPART E [§ 201.150 - § 201.161] - Subpart E—Other Exemptions
- SUBPART F [§ 201.200 - § 201.200] - Subpart F—Labeling Claims for Drugs in Drug Efficacy Study
- SUBPART G [§ 201.300 - § 201.328] - Subpart G—Specific Labeling Requirements for Specific Drug Products